DIVISLAB's weekly performance was positive, with a return of 0.88%, outperforming its peers DRREDDY, SUNPHARMA, and CIPLA. The stock's volatility was relatively moderate at 14.64%, lower than its peers. The Sharpe Ratio of 0.32 indicates a decent risk-adjusted return. Overall, DIVISLAB was a relatively safe bet this week, with a lower max drawdown of -0.47%. 

[Volatility: 14.64%]